Global B2B Pharmaceutical Sourcing · Dossier Licensing · Named-Patient Access
💬 WhatsApp · Sign in · Register
Verapamil HCl tablets bulk supplier for pharma manufacturers

Verapamil HCl Tablets 240 mg once daily Suppliers & Bulk Manufacturers

Available Forms: Sustained-release tablets

Available Strengths: 240 mg once daily

Reference Brands: Covera-HS®

Category: Drugs Using Osmotic Pump Systems

Verapamil hydrochloride extended-release tablets are a calcium channel blocker for high blood pressure, angina and some heart-rhythm problems. This 240 mg once-daily version uses an osmotic delivery system designed for bedtime dosing (reference product Covera-HS). Standard and sustained-release verapamil tablets are widely available generics. Ask PharmaTradz for a quote; we confirm the manufacturer, registration documents and lead time for your country.

Get Enquiry / Request Bulk Quote

Usually answered within 48 hours | GMP documents shared before you commit

Manufacture or export Verapamil HCl Tablets? List it or send an offer →

Product Description:

Covera-HS® (verapamil HCl) is regulated in the EU and US, supported by dossiers demonstrating safety, efficacy, and manufacturing quality compliant with GMP and MDR standards. In the US, FDA approval involved clinical validation, safety assessments, and GMP compliance. In the EU, CE marking certifies conformity with MDR standards. These formulations undergo validation, stability testing, and audits, with comprehensive documentation including safety profiles, clinical data, and manufacturing practices.

Verapamil HCl Tablets — third party manufacturing & bulk supply

Verapamil HCl Tablets 240 mg once daily is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.
Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.
Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Verapamil HCl Tablets is supplied as Sustained-release tablets — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Verapamil HCl Tablets listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Verapamil HCl Tablets →

Usually answered within 48 hours, with matched manufacturers, indicative prices and document status.

Back to Listing

Frequently Asked Questions

Covera-HS releases most of the drug in the early morning hours, when blood pressure and heart attack risk peak.

40, 80 and 120 mg immediate-release tablets, 120–240 mg sustained-release tablets and capsules, and 2.5 mg/ml injection.

It slows the heart, so it is used carefully with beta-blockers; it also raises levels of some statins, digoxin and other drugs metabolised by CYP3A4.

Related Products

Methylphenidate HCl Tablets

Strength:
18 mg, 27 mg, 36 mg, 54 mg ER tablets

Form: Extended-release (ER) tablets

Reference Brands: Concerta

View Details
Doxazosin Mesylate Capsules

Strength:
4 mg, 8 mg, and 12 mg

Form: Extended-release (ER) capsules

Reference Brands: Cardura XL

View Details
Carbamazepine Tablets

Strength:
200 mg, 300 mg, 400 mg

Form: Extended-release (XR) tablets

Reference Brands: Tegretol XR

View Details
Prazosin HCl Tablets

Strength:
1 mg, 2 mg, 5 mg,10 mg

Form: Extended-release (ER) tablets

Reference Brands: Alpress LP

View Details
Enquire Now

Usually answered within 48 hours | GMP documents shared before you commit

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.
WhatsApp us